TAKE Solutions Limited

Equities

TAKE

INE142I01023

Biotechnology & Medical Research

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-04-26 am EDT			5-day change	1st Jan Change
23.45 ^INR	-0.42%		+7.57%	+1.74%

Apr. 01	TAKE Solutions Limited Announces Resignation of P. Srinivasan as Company Secretary & Compliance Officer	CI
Feb. 13	TAKE Solutions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

TAKE Solutions Limited Approves the Shifting of Registered Office

November 08, 2023 at 02:22 am EST

TAKE Solutions Limited announced that at its board meeting held on November 8, 2023, approved the Shifting of registered office of the company from No. 27, Tank Bund Road, Nungambakkam, Chennai- 600034, Tamil Nadu, India to 56, Ragas Building, Dr. Radhakrishnan Salai, Mylapore, Chennai-600004, Tamil Nadu, India with effect November 8, 2023.

Latest news about TAKE Solutions Limited

TAKE Solutions Limited Announces Resignation of P. Srinivasan as Company Secretary & Compliance Officer	Apr. 01	CI
TAKE Solutions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
TAKE Solutions Limited Approves the Shifting of Registered Office	Nov. 08	CI
TAKE Solutions Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
TAKE Solutions Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
TAKE Solutions Limited Auditor Raises 'Going Concern' Doubt	23-07-16	CI
TAKE Solutions Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
TAKE Solutions Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Take Solutions Divests Thailand-Based Arm	23-04-04	MT
An unknown buyer acquired Navitas Life Sciences Company Limited from TAKE Solutions Limited for $0.19 million.	23-03-31	CI
TAKE Solutions Completes Dissolution of US-based Unit	23-03-13	MT
TAKE Solutions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
TAKE Solutions Limited Appoints Kiran Sharma as an Additional Director (Non-Executive Independent Category)	23-02-14	CI
Take Solutions Names New CFO	23-01-01	MT
TAKE Solutions Limited Appoints Mr. Venkatesan. V as Chief Financial Officer	22-12-30	CI
TAKE Consultancy Services Inc announced that it expects to receive funding from TAKE Solutions Limited	22-10-17	CI

Chart TAKE Solutions Limited

Duration

Period

More charts

Company Profile

TAKE Solutions Limited is an India-based company, which provides domain-intensive services as a full-service clinical research organization (CRO) supporting pharma, biotech, and devices companies across the world. The Company operates through two segments: Life Sciences and Supply Chain Management. It offers full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its services spans from clinical trials to regulatory submissions to post-marketing safety. It provides services in life sciences sector across the spectrum of clinical, regulatory, safety and pharmacovigilance, networks, and consulting to deliver end-to-end solutions and services across processes, technology, and analytics to both domestic and global clients. It also provides information technology (IT) infrastructure and support, engineering, designing, and sourcing services. The Company operates in North America, Europe, Asia, and South America.

Sector

Biotechnology & Medical Research

Calendar

2024-05-15 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
TAKE SOLUTIONS LIMITED	+1.74%	41.12M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research